IntegriChain, delivering Life Sciences’ only comprehensive data and business process platform for market access, announced Thursday that it has acquired Blue Fin Group, a full-service professional management consulting firm delivering research, strategy, and implementation services to help manufacturers optimize access. More than 300 Life Sciences manufacturers – spanning cell and gene therapies, orphan/rare, specialty, primary care, vaccines, biosimilars, and generics – have relied on Blue Fin Group to optimize patient outcomes by orchestrating marketing, market access, field sales, pharmacy and distribution, and patient services as a seamless commercial strategy.
Read the full article: IntegriChain Acquires Blue Fin Group //
Source: https://www.prnewswire.com/news-releases/integrichain-acquires-blue-fin-group-combining-therapy-commercialization-expertise-with-leading-technology-data-and-business-operations-301464973.html